Stewart J Tepper

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Medication-overuse headache
    Stewart J Tepper
    Cleveland Clinic, Headache Center, Cleveland, OH, USA
    Continuum (Minneap Minn) 18:807-22. 2012
  2. doi request reprint Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia
    Stewart J Tepper
    Neurological Institute, Cleveland Clinic Center for Headache and Pain, Cleveland, OH 44195 0002, USA
    Headache 52:37-47. 2012
  3. pmc MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195 0002, USA
    Mayo Clin Proc 86:948-55. 2011
  4. doi request reprint Acute treatment of migraine
    Stewart J Tepper
    Center for Headache and Pain, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Neurol Clin 27:417-27. 2009
  5. ncbi request reprint Patent foramen ovale and migraine: association, causation, and implications of clinical trials
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 13:221-6. 2009
  6. doi request reprint Breaking the cycle of medication overuse headache
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:236-42. 2010
  7. doi request reprint Sumatriptan/naproxen sodium combination for the treatment of migraine
    Catalina Cleves
    Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA
    Expert Rev Neurother 8:1289-97. 2008
  8. doi request reprint QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 2: review of headache medications, drug-drug interactions, QTc prolongation, and other arrhythmias
    Mark J Stillman
    Headache Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 53:217-24. 2013
  9. ncbi request reprint Cluster headache: potential options for medically refractory patients (when all else fails)
    Stewart J Tepper
    Headache Center, Neurological Center for Pain, Cleveland Clinic, Cleveland, OH, USA
    Headache 53:1183-90. 2013
  10. doi request reprint Adverse effects of medications commonly used in the treatment of migraine
    Chad A Whyte
    Center for Headache and Pain, Cleveland Clinic Foundation, 9500 Euclid Ave T33, Cleveland OH 44195, USA
    Expert Rev Neurother 9:1379-91. 2009

Detail Information

Publications15

  1. doi request reprint Medication-overuse headache
    Stewart J Tepper
    Cleveland Clinic, Headache Center, Cleveland, OH, USA
    Continuum (Minneap Minn) 18:807-22. 2012
    ..This review will describe (1) MOH clinical features and diagnosis, (2) pathophysiology and structural and functional MOH brain changes, and (3) prevention and treatment of MOH...
  2. doi request reprint Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia
    Stewart J Tepper
    Neurological Institute, Cleveland Clinic Center for Headache and Pain, Cleveland, OH 44195 0002, USA
    Headache 52:37-47. 2012
    ..The efficacy of triptans for migraine resolution has been shown to be markedly reduced when administered in patients with established cutaneous allodynia...
  3. pmc MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195 0002, USA
    Mayo Clin Proc 86:948-55. 2011
    ..To evaluate the efficacy of MAP0004, an orally inhaled dihydroergotamine, for acute treatment of migraine when administered at various time points from within 1 hour to more than 8 hours after migraine onset...
  4. doi request reprint Acute treatment of migraine
    Stewart J Tepper
    Center for Headache and Pain, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Neurol Clin 27:417-27. 2009
    ..Opioids and butalbital should be avoided in acute migraine treatment. Triptan type can be selected for patients by differences in speed or effect, formulation, and formulary tier...
  5. ncbi request reprint Patent foramen ovale and migraine: association, causation, and implications of clinical trials
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 13:221-6. 2009
    ..Difficulty with recruitment closed the MIST II and ESCAPE trials; the PREMIUM and PRIMA randomized controlled trials are ongoing at the time of this writing...
  6. doi request reprint Breaking the cycle of medication overuse headache
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:236-42. 2010
    ..Breaking the cycle involves weaning the patient from the overused medications, setting up a preventive regimen, and setting strict limits on the use of medications to relieve acute symptoms...
  7. doi request reprint Sumatriptan/naproxen sodium combination for the treatment of migraine
    Catalina Cleves
    Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA
    Expert Rev Neurother 8:1289-97. 2008
    ..The clinical advantage of the sumatriptan and naproxen sodium combination is likely to be prolonged benefit per attack, that is, a sustained pain-free response...
  8. doi request reprint QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 2: review of headache medications, drug-drug interactions, QTc prolongation, and other arrhythmias
    Mark J Stillman
    Headache Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 53:217-24. 2013
    ..This may be the place to start in protecting patients from these cardiac adverse events...
  9. ncbi request reprint Cluster headache: potential options for medically refractory patients (when all else fails)
    Stewart J Tepper
    Headache Center, Neurological Center for Pain, Cleveland Clinic, Cleveland, OH, USA
    Headache 53:1183-90. 2013
    ....
  10. doi request reprint Adverse effects of medications commonly used in the treatment of migraine
    Chad A Whyte
    Center for Headache and Pain, Cleveland Clinic Foundation, 9500 Euclid Ave T33, Cleveland OH 44195, USA
    Expert Rev Neurother 9:1379-91. 2009
    ..This article reviews adverse events associated with migraine and medications, and their implications in clinical treatment...
  11. doi request reprint Neurostimulation for primary headache disorders: Part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation
    Brian Jenkins
    Neurological Center for Headache and Pain, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 51:1408-18. 2011
    ..Part 2 also analyzes overall therapeutic efficacy, safety, cost, patient selection, and recommendations for further research of neurostimulation modalities based on available data...
  12. doi request reprint Dihydroergotamine and its use in migraine with posterior fossa symptoms
    Chad A Whyte
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Headache 50:1419-23. 2010
    ..Dihydroergotamine (DHE) has been used for decades to treat migraine, but is currently contraindicated in patients with hemiplegic migraine and basilar-type migraine (BTM)...
  13. doi request reprint Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI
    Stewart J Tepper
    Cleveland Clinic Headache Center, Cleveland, OH 44195, USA
    Headache 52:236-43. 2012
    ..Magnetic resonance imaging (MRI) findings of iron accumulation in the brain, especially in periaqueductal gray and red nucleus, have been correlated with both duration of illness and frequency of attacks...
  14. doi request reprint Headache following intracranial neuroendovascular procedures
    Eric P Baron
    Cleveland Clinic Neurological Institute Neurology, Center for Headache and Pain, Center for Regional Neurology, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Headache 52:739-48. 2012
    ....
  15. ncbi request reprint Acute treatment of migraines
    Arnaldo N Da Silva
    Center for Headache and Pain, Cleveland Clinic, Cleveland, OH 44195, USA
    CNS Drugs 26:823-39. 2012
    ..Narcotics and habituating medications should be avoided in the acute treatment of migraine, as the risk for transformation to chronic daily headache is excessively high at a relatively infrequent rate of exposure...